EANS-Adhoc: Curanum AG
Results of Q1/ 2009
ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
quarterly report
15.05.2009
Ad hoc announcement
CURANUM presents Q1 report: occupancy stable in the first quarter
Occupancy across the Group was stable in the first quarter of 2009. Revenue amounted to EUR63.1 million in the quarter just elapsed (previous year: EUR63.7 million). The key factors behind this trend were, firstly, an approximately 1.5% higher occupancy in the first quarter of 2008, and, secondly, around EUR0.7 million of absent revenue compared with the 2008 leap year due to the fact that there was one day less in February 2009.
The personnel expense rose to EUR32.1 million (previous year: EUR31.5 million), and the rental expense increased to EUR13.9 million (previous year: EUR13.8 million). Earnings before interest, tax, depreciation and amortization (EBITDA) fell from EUR7.9 million in the first quarter of 2008 to EUR6.4 million in the first quarter of 2009. The EBITDA margin fell from 12.3% to 10.1% in the reporting period just elapsed.
EBIT amounted to EUR4.0 million in the first quarter of 2009 (previous year: EUR5.5 million), and earnings after tax reduced to EUR1.1 million (previous year: EUR2.2 million). Earnings per share fell accordingly from EUR0.07 to EUR0.04 per share in the first quarter of 2009.
Gross cash flow from operating activities (before changes in provisions and working capital) fell only slightly, and amounted to EUR4.2 million in the reporting period, compared with gross cash flow of EUR4.7 million in the previous year. Taking changes in provisions and working capital into account, cash flow from operating activities totaled EUR2.6 million (previous year: EUR4.1 million).
Equity increased slightly from EUR66.6 million as of December 31, 2008 to EUR67.0 million as of the end of the first quarter of 2009. This corresponds to an equity ratio of 27.8%.
As far as the full 2009 financial year is concerned our budget (excluding acquisitions) envisages revenue of EUR257 million to EUR259 million, EBITDA of EUR27.5 million to EUR29.0 million, and net profit of between EUR6.5 million and EUR8.5 million.
Munich, May 15, 2009
The Management Board
end of announcement euro adhoc
Further inquiry note:
Bettina Pöschl
Tel. +49(0)89-242065-69
E-Mail: bettina.poeschl@curanum.de
Branche: Healthcare Providers
ISIN: DE0005240709
WKN: 524070
Index: SDAX, CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Hamburg / free trade
Stuttgart / free trade
Düsseldorf / free trade
München / regulated dealing